What to Expect From Apple and More Dow Stocks Reporting on Tuesday

24/7 Wall St. has put together a preview of the Dow Jones Industrial Average companies scheduled to report their quarterly results this week.

Published May 1, 2017, 11:30am ET · 2 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

© Thinkstock

[cnxvideo id=”625445″ placement=”ros”]24/7 Wall St. has put together a preview of the Dow Jones Industrial Average companies scheduled to report their quarterly results on Tuesday. Most of the companies in the Dow have already reported their earnings and only a few remain. Although the Dow has slightly backed off its highs, the index is still showing some strength. A strong earnings showing from these companies could even the push the index past the 21,000 mark again.

We have included the consensus earnings estimates from Thomson Reuters, as well as the stock price and trading history.

Apple Inc. (NASDAQ: AAPL) is scheduled to reveal its fiscal second-quarter results late on Tuesday. The consensus forecast calls for $2.02 in earnings per share (EPS) and $52.97 billion in revenue. Shares were trading near $146.20 early on Monday. The consensus price target is $149.96. The stock has a 52-week trading range of $89.47 to $146.29.

[nativounit]

Pfizer Inc. (NYSE: PFE) is set to report its first-quarter results in the morning. The analysts’ consensus estimates call for EPS of $0.67 and $13.09 billion in revenue. Shares were trading near $33.85. The consensus price target is $37.80, and the 52-week range is $29.83 to $37.39.

Merck & Co. (NYSE: MRK) is also expected to report its most recent quarterly results before the opening bell. The consensus earnings estimates are $1.39, per share, on revenue of $7.5 billion. Shares of Merck were last seen near $62.25, in a 52-week range of $53.06 to $66.80.

[wallst_email_signup]

Contact [email protected] for any questions or corrections.

Chris Lange

Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.

His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.

When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.

All articles →